TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com
Equities research analysts at StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a report issued on Thursday. The firm set a “hold” rating on the stock. TherapeuticsMD Price Performance Shares of TXMD opened at $1.46 on Thursday. TherapeuticsMD has a 1-year low of $0.70 and a 1-year high of $2.44. […]
Equities research analysts at StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a report issued on Thursday. The firm set a “hold” rating on the stock. TherapeuticsMD Price Performance Shares of TXMD opened at $1.46 on Thursday. TherapeuticsMD has a 1-year low of $0.70 and a 1-year high of $2.44. […]
